CRISPR/Cas9 technology generated a C to G change at position 240, resulting in a phenylalanine to leucine substitution at amino acid 80 (p.F80L), which is a conserved residue in the THAP DNA binding domain. (J:317822)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count